Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
8-k | 8K-related | 14 | May 24, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 16, 2024 |
10-q | Quarterly Reports | 77 | May 09, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |